AlphaMaven

Company Logo'

Private Equity

Nordic ESG And Impact Fund SPSp

AV Group Sarl
Request More Information

Investment Overview

Strategy Description

AV Group Sarl. has established the Nordic ESG and Impact Fund, LP. in a Public-Private Partnership (PPP) with the Norwegian Government, to co-invest in strategic opportunities stemming from the Norwegian Venture Capital market and Renewable Energy/Infrastructure. AVG is inviting investors to join the Fund to take advantage of strategic deal flow in the following target sectors; clean tech, renewable energy, fintech, ICT and sustainable technologies. The Government support includes matched equity, grants, forgivable loans, favorable credit terms, expansion and marketing support. AVG's strong track record and experienced team, combined with Norwegian Government support, enables the Fund to target above average, risk-adjusted returns.
Principals

Christopher Coolidge
Christopher Coolidge - Advisor, AV Group Sarl
Investment Highlights

Investment Category

Private Equity

Investment Strategy

Private Investments, ESG

Investment Structure

Fund

Objective

Our Performance Goal
15-20%+ Annual Returns

Investment Opportunity

What We Believe
The Fund focuses on Climate Solutions in the Impact market.

Return Driver - Alpha

Our Edge
Proprietary Database
Implementation of Strategy
Tactical Approach

Market Sector Exposure

Private Equity

Capitalization Weight

Small Cap

Geographical Exposure

Global

Average Timeframe

Fund Life - 4 Years

Risk Management

Active management
Investment Structure

Legal Structure

Limited Partnership

Domicile

Luxembourg

Fund Minimum Investment

$1MM

Strategy AUM

$60MM

Firm AUM

$60MM

Management Fee (%)

2%

Incentive Fee (%)

20%
Service Providers

Administrator

Sanne Group plc

Auditor

KPMG Investment Advisory

Legal

AKD

Custodian/Bank

ING Bank
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.
You May Also Enjoy The Following Posts
Andrea Alms Video:  Money In Motion 100 - Cancer Market Wrap-Up
2w ago PrivateEquity BrookDell Partners
Oxford Algorithms AI Fund Overview Of February 2024 Performance
1mo ago HedgeFund Oxford Algorithms AI Fund
Andrea Alms Video:  Money In Motion 102 - Deep Dive Immunotherapy Cancer Market Part 3
2w ago PrivateEquity BrookDell Partners
Ridgedale Commodity Solutions Newsletter - March 2024
6d ago HedgeFund Ridgedale RMAC Index Plus
Andrea Alms Video:  Money In Motion 101 - Deep Dive - Immunotherapy Cancer Market
2w ago PrivateEquity BrookDell Partners
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.